Bio-Techne Corp
TECH: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$79.00 | Wmrswjl | Xkyrbcbg |
Bio-Techne Should Benefit from Biologics Growth, but Faces Risk of Cuts to Academic Research
Business Strategy and Outlook
Bio-Techne is a market-leader in proteins for the pharma, biotech, academic, and diagnostic markets, and maintains strong market positioning in both antibodies and testing controls for diagnostic partners.